FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to derivatives of pentadicarboxylic acid of the general formula (I): or to their acceptable salts and solvates wherein X represents compound of the formula: wherein Z represents -SH; R8 means -(CH2)2COOH; A means -CR17R18-; R9 means hydrogen atom; R10, R11, R17 and R18 mean hydrogen atom, unsubstituted or substituted (C1-C9)-alkyl. Also, invention describes a pharmaceutical composition based on the claimed compounds. Compounds are designated for inhibition of enzymatic activity of enzyme NAALADase that provides the possibility for treatment of such diseases as ischemia, insult and schizophrenia by using these compounds.
EFFECT: valuable medicinal properties of compounds, improved treatment of diseases.
10 cl, 26 dwg, 7 tbl, 14 ex
Title | Year | Author | Number |
---|---|---|---|
1-((3S,4R)-4-(3-FLUOROPHENYL)-1-(2-METHOXYETHYL)PYRROLIDIN-3-YL)-3-(4-METHYL-3-(2-METHYLPYRIMIDIN-5-YL)-1-PHENYL-1N-PYRAZOL-5-YL)UREA AS A TRKA KINASE INHIBITOR | 2015 |
|
RU2719489C2 |
ASK1-INHIBITING PYRROLOPYRIMIDINE AND PYRROLOPYRIDINE DERIVATIVES | 2018 |
|
RU2772422C2 |
DIPEPTIDYL KETOAMIDE META-METHOXYPHENYL DERIVATIVES AND THEIR USE | 2019 |
|
RU2787766C2 |
CYSTATHIONINE-γ-LYASE (CSE) INHIBITORS | 2013 |
|
RU2661879C2 |
PYRAZOLE-AMIDE COMPOUND AND MEDICINAL USES THEREFOR | 2014 |
|
RU2664532C2 |
ENDOTHELIN ANTAGONISTS: N-[[2'-[[(4,5-DIMETHYL-3-ISO-XAZOLYL)AMINO]SULFONYL]- 4-(2-OXAZOLYL)[1,1'-BIPHENYL]-2-YL]METHYL]-N,3,3-TRIMETHYLBUTANEAMIDE AND N-(4,5-DIMETHYL-3-ISOXAZOLYL)-2'-[(3,3-DIMETHYL-2-OXO-1- PYRROLIDINYL)METHYL]-4'-(2-OXAZOLYL)[1,1'-BIPHENYL]-2-SULFONEAMIDE AND THEIR SALTS | 1998 |
|
RU2183632C2 |
NOVEL CHROMAN-2-ONE DERIVATIVES AND USE THEREOF AS MONOAMINE NEUROMEDIATOR REUPTAKE INHIBITORS | 2005 |
|
RU2382040C2 |
PHENYLACETIC ACID DERIVATIVES AS COG-2 (CYCLOOXYGENASE-2) INHIBITORS | 2007 |
|
RU2454402C2 |
N-PYRROLIDINYL-UREA, N'-PYRAZOLYL-UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS | 2013 |
|
RU2677667C2 |
NEW GLUTAMINE CYCLASE INHIBITOR AND ITS APPLICATION | 2018 |
|
RU2791703C2 |
Authors
Dates
2006-01-27—Published
1999-07-02—Filed